Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-30 @ 2:23 PM
Study NCT ID:
NCT06249867
Status:
RECRUITING
Last Update Posted:
2025-09-05
First Post:
2024-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
Sponsor:
Oliver Blanchard
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2027-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-22
First Submit QC Date:
None
Study First Post Date:
2024-02-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-28
Last Update Post Date:
2025-09-05
Last Update Post Date Type:
ESTIMATED